Travere Wins PM360 Trailblazer Specialty Pharma/Biotech Company of the Year Award for its Work in Rare Disease

Friday, September 23, 2022 — We are grateful to be recognized as the 2022 PM360 Trailblazer Specialty Pharma/Biotech Company of the Year award winner for our work in rare disease. Trailblazer awards are decided by a cross-section of experts from across the industry evaluating companies for innovation, talent development, and social responsibility. Read the full list of winners.